1drop

1drop is a biomedical technology company based in Seongnam-si, South Korea, that develops mobile healthcare solutions and point-of-care diagnostic test kits. The company's core technology utilizes commercial smartphone cameras to perform in vitro diagnostics, allowing users to measure biomarkers such as blood glucose and uric acid from a single drop of blood. Operating with a team of 15 employees, the enterprise has secured $4.3 million in venture funding across multiple rounds, including a Series C financing. The medical device manufacturer has achieved CE-IVD certification for more than five of its products in Europe, including its COVID-19 RT-PCR test kits. 1drop originally spun out of the Samsung Electronics C-Lab program and is backed by institutional investors such as Company K Partners, KB Investment, and IMM Investment. The organization was founded in 2017 by Joowon Hahn.